Dr. Wafik El-Deiry, MD, PhD, FACP

Media Releases

Dr. El-Deiry, a Leading Authority in Oncology, Continues to Revolutionize Cancer Treatment Strategies and Patient Care

An esteemed figure in the medical world, Dr. El-Deiry has garnered recognition for his outstanding contributions to the field of oncology. As the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and the Director of the Cancer Center at Brown University, he plays a pivotal role in shaping the future of cancer research and patient care. His leadership extends to overseeing the Joint Program in Cancer Biology, a collaborative initiative involving Brown University and affiliated hospitals, aimed at fostering interdisciplinary research and enhancing clinical outcomes.

With a distinguished background that combines medical expertise and significant research achievements, he has made remarkable strides in understanding cancer biology and developing innovative treatment approaches. Specializing in the care of patients with colorectal cancer and rare genetic drivers of other tumor types, he is a driving force in advancing oncologic sciences.

Boasting an impressive educational background that includes MD and PhD degrees from the University of Miami School of Medicine, Dr. El-Deiry completed his medical training at prestigious institutions such as the Johns Hopkins Hospital and the Johns Hopkins Oncology Center. His expertise has been further recognized through his appointment as an American Cancer Society Research Professor, solidifying his reputation as a leading expert in the oncology field.

His impactful research has led to groundbreaking discoveries in cancer biology, notably his pioneering work in defining the genomic DNA-binding consensus sequence for the p53 tumor suppressor protein. His identification of p53 target genes and the CDK inhibitor p21(WAF1) has significantly advanced our understanding of tumor suppression mechanisms and cell cycle regulation, leading to the development of FDA-approved CDK inhibitor drugs that have revolutionized cancer therapy.

Throughout his illustrious career, Dr. El-Deiry has held key positions at esteemed institutions, including the University of Pennsylvania School of Medicine, where he served as a Professor of Medicine, Pharmacology, and Genetics. His tenure as a Howard Hughes Medical Institute Investigator further underscores his exceptional contributions to biomedical research, inspiring the next generation of oncologists and researchers.

Dr. El-Deiry's relentless dedication to translating cutting-edge research into tangible clinical outcomes continues to shape the landscape of oncology, offering hope to patients and driving progress in the fight against cancer.

Recommended Articles

• Political Architect and Clinton Ally, Nancy McFadden Dies of Ovarian Cancer

  Nancy McFadden, a lawyer and an influential political advisor to Bill Clinton and Jerry Brown, sadly lost her tiring battle with ovarian cancer on Thursday, March 22nd 2018. She passed away at the age of 59 in her Sacramento home.Governor Brown made a statement the following day, on March 23rd,...

• Ovarian Cancer Is Not Only Deadly, But Very Hard to Detect. Women Need to Stay Vigilant

  September is known as Ovarian Cancer Awareness Month. Ovarian cancer is a type of cancer of the cells of the ovaries. It can occur in several different parts of the ovary, including the germ, stromal or epithelial cells. Germ cells are the cells that become eggs, stromal cells make up the substance...

• A Breast Cancer Conversation Between Grandmother and Granddaughter

  In 2014, Bonnie Annis was diagnosed with stage 2b invasive ductal carcinoma with metastasis to the lymph nodes. Today, she is a breast cancer survivor. She dedicates her time to freelance writing/blogging and photography and she is a devoted wife, mother, and grandmother. Bonnie, like a majority of...

• Study Finds Risks of Damage to the Ovaries from Chemotherapy For Hodgkin’s Lymphoma in Women 35 and Older

  It is well known that chemotherapy drugs work by warding off cancer cells or stopping them from multiplying. However, they can also affect some of the healthy cells within the body. This, in turn, can cause unwanted side effects, such as reduced fertility. The likeliness of one’s fertility being...

• What Tests Determine Multiple Myeloma?

  Multiple myeloma is a rare form of blood cancer where the bone marrow has cancerous plasma cells. Plasma cells are responsible for generating antibodies, which are important in the immune system, as they are the proteins responsible for fighting specific diseases. Multiple myeloma is a cancer caused...

• Alternative Treatment for Prostate Cancer

  Prostate cancer has become a common disease in men, especially those aged from 50 years and above. Having prostate cancer comes with its own effects that no one wants to be part of. Various symptoms accompany an affected prostate gland. Such symptoms may include pain when urinating, high frequency...